The Week in Science and Science Policy May 8th-15th

By | May 15, 2017

The forces shaping biopharma in China While the United States has long led the world in biotech research and industry, China is catching up quickly. The Chinese government has identified biotechnology and synthetic biology as of crucial importance to defense, industry, and medicine, and drawn up detailed plans for the future of Chinese science. In… Read More »

The Week in Science and Science Policy May 1st-8th

By | May 8, 2017

1. Science gets a budget deal that’s better that we’d hoped for Waiting on President Trump’s signature is a budget deal of a little over $1 trillion, including continued funding for scientific research. While environmental research sees some cuts, most biomedical research will maintain similar levels of funding to what has previously been provided. This… Read More »

The Week in Science and Science Policy April 23rd-30th

By | May 1, 2017

1. The problem of secrets in private biotech In the face of potential cuts to federal science funding, private industry is increasingly a potential source of research funding. While federal funding peaked in the middle of the last century, private funding has only been increasing, and will continue to. This does not mean that private… Read More »

My Picks in Science Policy April 16th-April 23rd

By | April 24, 2017

Of course, the big news this week was the Science March. With practically every news outlet hosting think-pieces and op-eds about the march, it seemed like other articles about science and science policy were pushed out of the public eye a bit. I’ll share a list of science march articles at the end, but for… Read More »

My picks in Science Policy April 9th-15th

By | April 16, 2017

1. The problems with cancer research cell lines As a cancer biologists, there are several breast cancer cell lines I use every day. Some of these are derived from human tumors, some from mouse tumors that closely mimic what we see in human patients. However, we’ve known for a long time that cell lines don’t… Read More »

My Picks in Science Policy April 1st – 8th

By | April 10, 2017

Why does it matter that the President has no Science Advisor? One of the positions that remains unfilled in the Trump white house is that of science advisor. In this article, Obama’s science advisor, John P. Holdren, goes into what the presidential science advisor does, what the history of the role is, and why the… Read More »

My Picks in Science Policy March 17-24

By | March 26, 2017

  1. What should the role of NASA be going forwards? Federal funding plays a crucial role in high-risk, low-return discoveries. These lay the foundation for future research and industry, fostering economic growth. One of the best examples of this is with the space industry, while NASA conducted the initial research and exploration, it is now… Read More »

The best reads in science/science policy 03/10/-03/17/017

By | March 20, 2017

The big news this week was the release of President Trump’s initial budget plan. If you haven’t taken the chance to take a look at it yet, be sure to read up on its potentially devastating effects, how Republicans in Congress are responding to it, and what happens next. While this is what’s on everybody’s… Read More »